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ABSTRACT 
Recently, new emphasis was put on reducing waiting times in mental health services as there is 
an ongoing concern that longer waiting time for treatment leads to poorer health outcomes. 
However, little is known about delays within the mental health service system and its impact on 
patients. We explore the impact of waiting times on patient outcomes in the context of Early 
Intervention in Psychosis (EIP) services in England from April 2012 to March 2015. We use the 
Mental Health Services Data Set and the routine outcome measure the Health of the Nation 
Outcome Scale. In a generalised linear regression model, we control for baseline outcomes, 
previous service use and treatment intensity to account for possible endogeneity in waiting time. 
We find that longer waiting time is significantly associated with a deterioration in patient 
outcomes 12 months after acceptance for treatment for patients that are still in EIP care. Effects 
are strongest for waiting times longer than 3 months and effect sizes are small to moderate. 
Patients with shorter treatment periods are not affected. The results suggest that policies should 
aim to reduce excessively long waits in order to improve outcomes for patients waiting for 
treatment for psychosis. 
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1. INTRODUCTION 
Waiting times are a notable phenomenon in publicly funded health care systems such as the 
English National Health Service. Waiting lists can serve to stock available demand and optimise 
utilisation of the scarce supply of resources such as skilled staff and medical equipment (Culyer 
et al., 1976). However, concerns arise when cases are affected in which waiting time may impede 
the patient’s utility gain from the treatment. In the case of psychosis, timely access to care is 
considered a key priority in successful treatment. It has significant implications for the 
prevention of impairments and disabilities, functional and symptomatic recovery, as well as the 
level of treatment engagement of patients (Doyle et al., 2014; Penttilä et al., 2014). This is why 
recently, new emphasis has been placed on reducing waiting times in mental health services with 
the introduction of  maximum waiting time targets for Early Intervention in Psychosis (EIP) 
services in England (NHS England et al., 2015). But to date little is known about delays within 
the mental health service system and their impact on patients.  
This paper seeks to improve the understanding of the relationship between waiting times and 
patient outcomes in the context of EIP services in England. We investigate whether the time from 
acceptance onto the EIP caseload to start of treatment, not only leads to a deterioration in the 
patient’s condition while waiting but also impedes the patient’s ability to benefit from treatment 
up to 12 months after the start of treatment. The distinct feature of EIP services is that treatment 
is delivered over several months or years and treatment intensity can vary from patient to patient. 
Further, recovery in psychosis is a long lasting process where keeping patients in a stable 
condition is considered a good outcome (Revier et al., 2015). Rather than looking at the outcomes 
immediately after a single treatment event as in previous literature, we look at patient outcomes 
after 12 months, incorporating treatment intensity during this time period. Our outcome measure, 
the Health of the Nation Outcome Scale (HoNOS), comes with a number of advantages for our 
analysis. Being clinician-reported, it provides a measure of patient outcome, independent of the 
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patient’s subjectivity, which on the one hand is a desired dimension in patient-reported measures 
(Fitzpatrick et al., 1998) but may be challenging for people with severe mental illness (McCabe 
et al., 2007; Reininghaus et al., 2012). Previous work on waiting times using other outcome 
measures consistently found low to moderate effect sizes – it is however questionable whether 
effects that are statistically significant but small are also clinically relevant. We advance the 
analysis by estimating the impact of waiting time on a clinically reliable and significant change 
in HoNOS. While HoNOS is not specific to psychosis, it is routinely collected in administrative 
data which offers the potential to expand future analysis to other samples and mental health 
conditions in a comparable manner. As such, our work contributes to the literature discussing 
the feasibility and usefulness of routine outcome measures in general (Boswell et al., 2015) and 
for mental health conditions in particular (Gilbody et al., 2003; Tasma et al., 2017). 
2. BACKGROUND 
2.1. Theoretical framework 
Waiting for treatment on a waiting list does not require patients to queue in person. Hence, there 
are no opportunity costs in terms of time spent waiting in order to clear markets. But still, waiting 
times impose costs, as introduced in the model of queuing by list by Lindsay et al. (1984). 
Patients join the waiting list in order to obtain the right to receive treatment at some point in the 
future. The value of obtaining this right depends on the price to be paid when receiving the 
treatment (which is zero in the case of no co-payments) and the delay (waiting time) to receive 
of the good. The delay effects are composed of two factors: First, a positive interest rate will lead 
to a discounted value of the good consumed in the future relative to its present value. Second, 
the time of delivery affects the present value of consumption due to, for example, pain, 
uncertainty, and disability. In other words, the treatment received tomorrow is worth less since 
the patient (and caring relatives) have to experience suffering and inconvenience of living with 
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a disease. Koopmanschap et al. (2005) further demonstrated theoretically that the negative 
impact of waiting time can be long-term. The deteriorated condition of the patient while waiting 
may take longer to recover or will not be reversed at all after a critical waiting time has passed. 
In the context of psychosis, the suffering can be significant. Psychoses summarise a group of 
serious mental health conditions in which a person's perception, thoughts, mood and behaviour 
are significantly altered (NICE, 2014). Patients experience a high degree of impairment and the 
often unusual or bizarre behaviour leads to difficulties in managing their own life up to the point 
of social exclusion (Huxley et al., 2003). Although psychosis affects people in the most 
productive period of their working lives (mid- to late-twenties), they face lower rates of 
employment, lower payment and less secure jobs (Marwaha et al., 2004; Revier et al., 2015). All 
of the above suggests that waiting for psychotic treatment will contribute to a deterioration in 
treatment outcomes as symptoms and impairments will worsen over time and patients may 
disengage with treatment (Doyle et al., 2014; Penttilä et al., 2014).  
2.2. Early intervention in psychosis services and treatment 
EIP services provide a full range of pharmacological, psychological, social, occupational and 
educational interventions (NICE, 2014). The main treatment options are antipsychotic 
medication in conjunction with psychological interventions such as cognitive behavioural 
therapy and family interventions. The psychological interventions are delivered in a number of 
planned sessions over a period of at least 3 to 12 months. Given the multidisciplinary nature of 
EIP services, the care coordinator plays a key role in the effective delivery of EIP care (NHS 
England et al., 2015). They not only bring together all different professionals involved in the 
care of the patient, such as therapists, social workers, and psychiatrists. They are also responsible 
for engaging patients in treatment and supporting them across the total spectrum of their needs. 
Each EIP service is governed by the responsible mental health trust as the provider, which in 
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turn negotiates the overall budget with a number of payers and distributes it to the individual 
services in charge. 
2.3. Related literature 
Two strands of literature shall be distinguished in the discussion of waiting times and outcomes. 
The first strand focuses on physical health conditions with most studies in the area of non-urgent 
surgical procedures such as hip and knee replacement (Braybrooke et al., 2007; Hamilton et al., 
1999; Hamilton et al., 1996; Hirvonen et al., 2007; Hirvonen et al., 2009; Ho et al., 2000; 
Nikolova et al., 2016; Quintana et al., 2011; Tuominen et al., 2009, 2010), or more urgent 
surgical procedures such as organ transplantation (Meier-Kriesche et al., 2000; Rauchfuss et al., 
2013), and coronary artery bypass surgery (Manji et al., 2013; Moscelli et al., 2016; Sari et al., 
2007). Fewer studies investigate the relationship of waiting time with non-surgical treatments 
such as rehabilitation (Collins et al., 2015; Pedersen et al., 2017), radiotherapy (Gupta et al., 
2016; Noel et al., 2012; Seidlitz et al., 2015), or HIV treatment (Su et al., 2016). Results are 
inconsistent as to whether longer waiting causes worse chances of functional remission, 
recurrence, treatment adherence, quality of life, and mortality. Most of these studies use field 
data which are limited in sample size, number of providers, and covariates to control for 
confounders. More recently, studies have used administrative data to overcome some of these 
limitations. Moscelli et al. (2016) found that waiting for coronary bypass surgery did increase 
the number of emergency readmissions but not in-hospital mortality. Nikolova et al. (2016) 
analysed the impact of waiting for elective surgery on patient-reported outcomes. They found 
that a longer waiting time reduces health-related quality of life for hip and knee replacement, but 
not for varicose veins and inguinal hernia. 
The second strand of literature focuses on the impact of treatment delays on outcomes regarding 
first episode of psychosis patients. The key measure of waiting time in this context is the duration 
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of untreated psychosis (DUP). DUP measures the time from the onset of the psychosis to the 
start of treatment and is mostly defined using patient interviews (Norman et al., 2001). Penttilä 
et al. (2014) recently published a comprehensive review of 33 studies. Longer DUP was 
associated with more severe symptomatic outcomes and reduced remission rates with small to 
moderate effect sizes. Also, longer DUP correlated with poorer social functioning but not with 
employment or quality of life. Some recent studies looked at long-term effects of DUP on 
outcomes. In a 20-year follow-up, Cechnicki et al. (2014) found significantly deteriorated 
outcomes for the long DUP group (> 6 months) in terms of symptom recovery, social 
functioning, and employment. Tang et al. (2014) reported significantly higher symptom 
remission rates for the shorter DUP group after accounting for confounding factors in a 13-year 
follow-up period. Despite the quantity of studies, evidence remains limited, since studies tend to 
be small-scale with sample sizes between 23 and 776 patients using only a single or a few 
providers. Attrition rates ranged from 4–71% which could be a source of significant selection 
bias. Most studies are based on purely correlational methods or do not account adequately for 
the typically skewed nature of DUP (Marshall et al., 2005; Norman et al., 2001).  
Our work aims to bridge the gap between these two distinct strands of literature. We advance the 
literature on psychotic patients by using well established methods from physical health care and 
a large, nationally representative sample. Our waiting time measure moves beyond the traditional 
concept of DUP to overcome some of its limitations. At the same time, we advance the literature 
in the physical health context by looking at a different treatment regime characterised by multiple 
treatment events over a period of several months. This stresses the importance of treatment 
intensity which we include in the analysis. 
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3. DATA AND KEY MEASURES 
We use the Mental Health Services Data Set which is a national administrative database of mental 
health related treatment in hospitals and community settings within the English NHS. Patients 
were included if they had a first EIP episode within the study period April 2012 to March 2014 
and followed up for a period of 12 months.  Figure 1 summarises the study timeline and 
measurement points. 
 
Figure 1 Study timeline with measurement points 
 
Our outcome measure, HoNOS, is routinely collected by providers in our dataset (Wing et al., 
1998; Wing et al., 1999). HoNOS is composed of 12 items covering the four sub-domains 
behaviour, impairment, symptoms, and social functioning (see Appendix A). Each item is 
evaluated by a trained clinician on a scale from 0 (no problem) to 4 (severe to very severe 
problems) and contributes equally to the total score ranging from 0 to 48. HoNOS measurements 
are conducted at treatment start and during the course of treatment. This allows us to observe a 
baseline HoNOS score at the start of the EIP episode and a score at follow-up at the end of the 
12 months (or at the end of the EIP episode if treatment ended before the follow-up). We use the 
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baseline measurement to condition on pre-treatment severity. Further, we determine whether 
patients improved reliably and in a clinically meaningful way using the concept of reliable and 
clinically significant change introduced by Jacobson et al. (1991) and applied to HoNOS by 
Parabiaghi et al. (2005).  
Inpatient waiting time as commonly used in physical health papers measures the time from the 
specialist’s decision to treat until the start of the inpatient treatment (Siciliani et al., 2014). We 
translate this concept to the context of psychosis by measuring the time from the patient’s 
acceptance onto the EIP caseload (decision to treat) to the assignment of a care coordinator (start 
of treatment). The care coordinator is the key requirement for effective treatment to be initiated 
(NHS England et al., 2015). Previous papers found the relationship between waiting time and 
outcomes to be non-linear with outcomes deteriorating significantly at a waiting time longer than 
1 month (Tang et al., 2014) or 3 months (Cechnicki et al., 2014). Therefore, we employ three 
different transformations of waiting time: (i) a log transformation of waiting time in days, (ii) 
waiting time quintiles with an equal number of patients in each group, (iii) waiting time intervals 
based on the thresholds typically used in the previous literature (0.5 to 3 months, 3 to 6 months, 
and 6 to 12 months). 
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4. METHODS 
4.1. The model 
We denote hijkl as the mental health status of the th-patient,  = 1,… , who lives in small area 
	,  = 1, … ,   and receives treatment at provider ,  = 1,… , in the financial year ,  =
1, … , 	. The health status is measured prior to treatment (ℎ
 ) and 12 months after treatment 
start (ℎ
 ) as the total HoNOS score. Formally, the model is specified as  
ℎ
 = 	
 + ℎ
 +  +  +  +  +  +    (1) 
where  represents the patient’s waiting time. The patient’s outcome prospects are likely to 
depend on the severity of the condition at baseline. We therefore condition on the baseline 
HoNOS score	ℎ
 . 	encompasses measures of treatment intensity. Over the 12-month 
follow-up period, treatment intensity will vary between patients but may also impact on the 
patient’s outcomes. We approximate treatment intensity by the following variables: (i) the 
number of days in EIP care, (ii) the number of days in inpatient care, and (iii) the number of 
mental health professional contacts until the end of follow-up (or end of EIP if earlier than 
follow-up). We further control for whether a patient was being detained under the Mental Health 
Care Act in that period since additional legislative requirements impose a higher level of 
treatment intensity. Since the degree to which each of the variables contributes to the patient’s 
recovery process is unknown, we include each of them with equal weight into the model. 
Patient characteristics that could impact both waiting time and outcomes are captured in . 
Alongside a range of demographic characteristics, we consider the patient’s socioeconomic 
background. At patient-level, we include accommodation and employment status. Further, we 
used socioeconomic deprivation based on the Index of Multiple Deprivation measured at small-
area level (McLennan et al., 2011). Previous mental health service use, represented by 	may 
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be indicative of the patient’s ability to navigate through the system and take advantage of 
treatment options (and thus impact waiting times as well as outcomes). The vector includes the 
number of inpatient stays (in intervals 0, 1-2, >2), outpatient episodes (in intervals 0, 1-2, >2), 
mental health professional contacts (in intervals 0, 1-10, >10), and primary as well as secondary 
diagnoses within the 12 months prior to the EIP start. There are 	 unobservable year effects  
and  unobservable provider-level effects  for the 48 mental health trusts in our sample. The 
term  represents the idiosyncratic error.  
Our main coefficient of interest is 
 which measures the effect of waiting time on follow-up 
HoNOS outcomes conditional on the included covariates. We expect follow-up outcomes to 
deteriorate if waiting time increases both because the waiting itself causes a worsening in the 
patient’s condition and because the waiting impedes the patient’s ability to benefit from 
treatment. Therefore, we expect a positive 
 indicating an increased (worse) follow-up HoNOS 
score. By the application of provider and time fixed effects, any variation has to be interpreted 
as within provider variation for a given year. 
Both the Shapiro-Wilk test (Shapiro et al., 1965) and the Shapiro-Francia test (Shapiro et al., 
1972) strongly rejected the null hypothesis of  ℎ

 being normally distributed. We accounted 
for the skewness by using generalised linear regression methods (Nelder et al., 1972) which were 
shown to be an adequate choice in typically skewed data (Jones et al., 2016; Sinko et al., 2016). 
The modified Park test confirmed the Poisson distribution to fit the data best. Both the Pregibon 
link test (Pregibon, 1980) and the modified Hosmer-Lemeshow goodness-of-fit test (Hosmer et 
al., 2005) accepted the square root link function. The RESET test (Ramsey, 1969) further 
confirmed the model specification. We used cluster robust standard errors for the 48 mental 
health trusts (see Appendix C). 
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4.2. Robustness checks 
We applied the same model from equation (1) to each sub-domain of HoNOS resulting in four 
separate models for behaviour, impairment, symptoms and social outcomes. We estimated this 
system of linear equations as a Seemingly Unrelated Regression model without constraints to 
account for cross-model covariance which was supported by the Breusch-Pagan Lagrange 
multiplier test for error independence (Zellner, 1962). Further, we use concept of clinically 
significant and reliable change (see Appendix B for more details) to test whether the effect size 
we measure is of clinical relevance. We employed an ordered probit model to predict the impact 
of waiting time on the probability of a clinically significant and reliable change in the HoNOS 
score conditional on the same set of covariates as introduced above. 
5. RESULTS 
5.1. Descriptive statistics 
We identified 14,912 patients (full sample) having a first EIP episode and a care coordinator 
within the study period. We excluded 5,874 patients (39.4%) for which we could not observe 
two complete HoNOS records. Another 89 patients (0.01%) were excluded which were from 
providers treating fewer than 30 patients in the sample. The remaining study sample included 
8,949 patients being treated within 48 mental health trusts. Table I compares key characteristics 
of the study sample with those from the full and the excluded sample. Our study sample was on 
average 25.8 years old, predominantly male, of White ethnicity, single, and diagnosed with 
schizophrenia. Most lived in mainstream housing within the most deprived neighbourhoods, and 
were unemployed. 
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Table I Descriptive statistics 
  Full sample Study sample Excluded sample 
Number of patients 14,912 8,949 5,963 
Number of providers 55 48 55 
Patient demographics       
Patient age (mean) 24.9 25.8 23.6 
Male (%) 63.7 63.6 64.0 
White ethnicity (%) 73.4 72.1 75.6 
Marital status: Single (%) 88.5 87.1 90.9 
Schizophrenia diagnosis (%) 53.6 52.9 55.2 
Socioeconomic background       
Mainstream housing (%) 83.5 83.6 83.3 
Unemployed (%) 45.2 47.4 41.1 
Least deprived quintile (%) 9.9 9.3 10.8 
Most deprived quintile (%) 37.8 38.1 37.3 
Mental health service use (before start of EIP care)       
Zero health professional contacts (%) 31.7 18.3 52.0 
Zero outpatient episodes (%) 73.7 68.0 82.3 
Zero inpatient admissions (%) 69.2 60.2 82.8 
Zero Mental Health Care Act section (%) 77.5 71.6 86.5 
HoNOS score at baseline (mean)       
Total (min 0, max 48) 14.0 14.1 13.5 
Behaviour score (min 0, max 12) 2.8 2.8 2.9 
Impairment score (min 0, max 8) 1.4 1.2 1.0 
Symptoms score (min 0, max 12) 5.7 5.7 5.5 
Social score (min 0, max 16) 4.4 4.4 4.1 
Treatment intensity (during EIP care)       
Days in EIP care (mean) 291.5 306.6 268.9 
Days in inpatient care (mean) 15.2 18.8 9.9 
Mental health professional contacts (mean) 36.6 42.5 27.7 
Mental Health Care Act sectioned (%) 20.5 23.9 15.3 
Note: HoNOS observations are reported for the total study sample and for n = 10,012 in the full sample and 
n = 1,063 in the excluded sample. 
 
The mean HoNOS score at baseline was 14.1. Figure 2 visualises the distributional shift of 
HoNOS scores towards zero from baseline to follow-up. During the 12 months follow-up, 
patients in the study sample spent on average 18.8 days in inpatient care and experienced 42.5 
contacts with any kind of mental health professional. 23.9% were sectioned under the Mental 
Health Care Act at least once during the time of follow-up. Our study sample was on average 
two years older than the excluded patients and more likely unemployed. Most evident is that 
patients in the study sample were more likely to have been in contact with mental health services 
- 14 - 
in the previous 12 months. Also, treatment intensity during the EIP care was higher for the study 
sample. Mean HoNOS scores at baseline were, however, very similar on all dimensions.  
 
Figure 2 Histogram of HoNOS scores at baseline and follow-up 
 
We note that not all patients spent the total follow-up time in EIP care. We therefore stratified 
the study sample by whether a patient finished EIP care before the end of follow-up (“short EIP” 
group, 31.4%) or not (“long EIP” group, 68.6%) and run analyses for the two subsamples 
separately. Table II shows that in all three samples, HoNOS decreased (improved) from baseline 
to follow-up by about 2 to 4 points. The short EIP group improved less in HoNOS but waited 
almost 15 days longer than the long EIP group. 
Table II Summary statistics of waiting time and HoNOS 
  Study sample Long EIP Short EIP 
  Mean SD Mean SD Mean SD 
Baseline HoNOS 14.1 6.8 14.1 6.8 14.0 6.8 
Follow-up HoNOS 10.6 7.0 10.1 6.9 11.7 7.2 
Waiting time 50.1 74.1 42.1 64.1 67.4 89.8 
Observations 8,949   6,135   2,814   
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Figure 3 summarises several descriptive statistics of our main explanatory variable, waiting time. 
As expected, we find waiting time to be heavily left skewed with a median of 20 and a mean of 
50 days. Consequently, the largest proportion of patients was allocated to the waiting time 
interval of less than 0.5 months (panel (b)). We also see that taking the logarithm of waiting time 
helps to reduce a large amount of the skewness (panels (c) and (d)). 
 
Figure 3 Descriptive statistics on waiting time 
 
Figure 4 visualises the distribution of HoNOS scores across the different waiting time intervals. 
Baseline HoNOS scores in panel (a) vary very little across intervals of waiting particularly for 
the first three intervals. While patients from the longest waiting interval had the lowest median 
HoNOS at baseline, they improved least at follow-up. Panel (b) shows that median follow-up 
scores decreased (improved) most at follow-up for the shorter waiting time intervals. 
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Figure 4 Box plots for HoNOS scores by waiting time intervals 
 
5.2. Estimation results 
Table III displays the estimation results from the regression of equation (1) including marginal 
effects (dy/dx). The estimates for the three different waiting time measures result from three 
independent regressions. Model (1) includes the whole study sample whereas models (2) and (3) 
look at long and short EIP patients respectively. We observe a significant but small effect of log 
waiting time on the HoNOS score 12 months after the EIP start for the total sample and the long 
EIP group. A 1% longer waiting time translates into an increase (worsening) in HoNOS by 0.20 
to 0.27 points. The association between longer waiting and worse outcomes is only significant 
for the longest waiting quintile – however with a larger effect than the overall. Being in the 
longest waiting quintile is associated with a 0.78 to 1.27 points higher (worse) HoNOS compared 
to the shortest waiting time quintile. For long EIP patients, we observe a clear gradient looking 
at the waiting time intervals. Patients waiting between 0.5 and 3 months (3 to 6 months; 6 to 12 
months) had a 0.34 (1.15; 1.61) higher HoNOS score than patients waiting less than 0.5 months. 
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Patients with an EIP episode shorter than the follow-up time seem to be not significantly affected 
by the length of waiting.  
Table III Generalised Linear Model results with follow-up HoNOS as dependent variable 
  (1) Study sample (2) Long EIP (3) Short EIP 
  Coeff. SE dy/dx Coeff. SE dy/dx Coeff. SE dy/dx 
Log waiting time (continuous) 0.032*** (0.009) 0.20 0.043*** (0.010) 0.27 0.022 (0.015) 0.15 
Waiting time quintiles (ref.cat.: shortest quintile)  
2nd shortest quintile -0.050 (0.036) -0.32 -0.015 (0.049) -0.09 -0.109 (0.064) -0.73 
3rd shortest quintile -0.057 (0.041) -0.36 0.004 (0.051) 0.02 -0.186** (0.060) -1.24 
4th shortest quintile 0.031 (0.033) 0.20 0.050 (0.039) 0.31 0.036 (0.081) 0.25 
Longest quintile 0.119** (0.045) 0.78 0.199*** (0.053) 1.27 0.021 (0.072) 0.14 
Waiting time intervals (ref.cat.: less than 0.5 months)  
Waiting time 0.5 to 3 months 0.040 (0.023) 0.25 0.054* (0.027) 0.34 0.034 (0.045) 0.23 
Waiting time 3 to 6 months 0.120*** (0.034) 0.78 0.181*** (0.048) 1.15 0.076 (0.052) 0.52 
Waiting time 6 to 12 months 0.215*** (0.059) 1.41 0.250*** (0.065) 1.61 0.189 (0.098) 1.30 
Observations 8,949     6,135     2,814     
Provider and year fixed effects yes     yes     yes     
Covariates yes     yes     yes     
Note: * p<0.05, ** p<0.01, *** p<0.001. Model (1) includes the complete study sample. Model (2) includes only patients with 
an EIP episode longer than the follow-up. Model (3) includes only patients with an EIP episode shorter than the follow-up. 
"dy/dx" represents average marginal effects in days. For factor levels they present the discrete change from reference category. 
All models use cluster robust standard errors for 48 provider clusters. 
 
Table IV reports the estimated coefficients and marginal changes of the baseline HoNOS as well 
as the treatment intensity variables based on equation (1). As expected, we observe a strong 
positive relationship between baseline and follow-up HoNOS scores. A higher or worse baseline 
condition strongly predicts worse outcomes 12 months after treatment start. Most severely 
affected patients had an up to 5 points worse outcome at follow-up. Overall, treatment intensity 
does not seem to impact outcomes much. Although significant, effect sizes are small. More days 
spent in EIP care seem to improve outcome prospects. Interestingly, more days of inpatient care 
and more mental health professional contacts are associated with a deterioration in follow-up 
outcomes. This may be explained by the fact that the two variables also capture some level of 
baseline severity of the patient that is not captured in the other control variables. In this case, 
more severe patients would need more inpatient care and service contacts but at the same time 
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have worse outcome prospects regardless of treatment intensity. For the short EIP group, we 
observe patients who were sectioned under the Mental Health Care Act to have significantly 
worse outcomes. This again may be explained by the variable capturing some different 
dimension of baseline severity, but it may also be an indication that involuntary treatment 
worsens outcome prospects. 
Table IV Generalised Linear Model results of baseline HoNOS and treatment intensity on 
follow-up HoNOS 
  (1) Study sample (2) Long EIP (3) Short EIP 
  Coeff. dy/dx Coeff. dy/dx Coeff. dy/dx 
Baseline HoNOS (ref.cat.: least severe)             
2nd least severe quintile 0.220*** 1.34 0.154*** 0.92 0.347*** 2.18 
3rd least severe quintile 0.310*** 1.92 0.268*** 1.63 0.404*** 2.57 
4th least severe quintile 0.400*** 2.51 0.297*** 1.82 0.620*** 4.08 
Most severe quintile 0.544*** 3.49 0.449*** 2.82 0.759*** 5.09 
Treatment intensity             
Number days in EIP care -0.001*** -0.01 - - - - 
Number of days in inpatient care 0.001* 0.00 0.001** 0.01 0.000 0.00 
Number of mental health professional contacts 0.005*** 0.03 0.005*** 0.03 0.004*** 0.03 
Sectioned under MHA within follow-up 0.023 0.15 -0.023 -0.15 0.153** 1.04 
Observations 8,949   6,135   2,814   
Provider and year fixed effects yes   yes   yes   
Covariates yes   yes   yes   
Note: * p<0.05, ** p<0.01, *** p<0.001.  All models include log waiting time as regressor. 
 
5.3. Robustness of results 
Results from the effects of waiting time on the different HoNOS sub dimensions are provided in 
Appendix D. In line with previous findings, we find the strongest negative impact of waiting 
time on the symptoms dimension. But also, all other sub dimensions are negatively affected by 
a longer waiting time. As before, patients waiting longer than 3 months are affected most by a 
deterioration in outcomes on each sub-domain. Although effect sizes are moderate, we find 
evidence of a significant increase in the probability of a reliable and clinically significant 
deterioration for the study sample and the long EIP group. The likelihood of a clinically relevant 
deterioration is again highest for the longest waiting patients (see Appendix E). 
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6. DISCUSSION 
Waiting times for mental health services in general and for EIP services in particular have 
recently gained considerable policy interest. But little is known about the detrimental effect of 
delays within the care system on outcomes for patients with psychosis. We document a moderate 
decline in patient outcomes 12 months after treatment acceptance for additional days of waiting. 
Despite moderate effect sizes, the risk of a clinically significant and reliable deterioration is 
elevated by longer waiting time. Effects are significant in the waiting time range from 3 to 12 
months which supports the threshold theory discussed in previous papers. Also consistent with 
previous literature, all outcome dimensions are affected with the largest impact on symptomatic 
and social outcomes. 
Our study contributes a number of aspects to existing evidence. First, we developed a strategy to 
measure a system-related waiting time measure in contrast to the commonly used DUP. DUP has 
been criticised in its suitability to measure service effectiveness as definitions vary considerably 
across studies and are prone to a self-report bias by patients (Norman et al., 2001; Register-
Brown et al., 2014; Singh, 2007). Our waiting time measure allows us to investigate the impact 
of delays within the care system rather than the help-seeking behaviour of patients (Gronholm et 
al., 2017). Second, we consider treatment intensity during the time of follow-up. It allows us to 
reflect recovery in psychosis as a long lasting process and patient outcomes as a result of repeated 
service contacts over a period of several months. Finally, we are the first to study a routine 
outcome measure (HoNOS) to look at psychosis outcomes. HoNOS has been found to have 
adequate or good validity, reliability, sensitivity to change, and feasibility (Amin et al., 1999; 
McClelland et al., 2000; Pirkis et al., 2005; Wing et al., 1998). Given its generic nature, it may 
lack clinical precision. But our findings are consistent with studies that use specific but 
heterogeneous outcome measures. 
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We note some limitations of our work. First, we may have underestimated waiting time as we 
excluded any waiting time that occurred between the first service contact (e.g. general 
practitioner) or self-referral and the specialist’s decision to treat. If longer waiting time does 
indeed have negative effects on outcomes, we would have estimated a lower bound of the effect. 
Second, we restricted our follow-up period and thus treatment intensity to 12 months given the 
boundaries of data availability. Longer follow-up has, however, been shown to increase the 
impact of waiting time on outcomes (Penttilä et al., 2014). If this is the case, then again, our 
results are a lower bound estimation. Third, our outcome measure demonstrates the clinician’s 
judgement of the patient’s condition which may not necessarily match the patient’s perception 
(Kramer et al., 2003). Fourth, this work is limited by the relatively high number of missing 
HoNOS records which is common when working with clinician-reported measures (Jacobs, 
2009). The remaining study sample had substantially higher proportions of mental health service 
contacts prior to the EIP treatment than excluded patients. This would have limited the external 
validity of our results if the relationship between waiting for treatment and outcomes of the same 
treatment would be different dependent on past service experience. On the one hand, patients 
may have learned coping strategies during previous service contacts which help them to 
deteriorate less during the time of waiting. On the other hand, patients with more service contacts 
in the past may be in a more severe condition overall which will worsen even more during 
waiting. Whereas in the first case we would have underestimated the negative impact of waiting 
time, we would have overestimated it if the latter case is true. Without further knowledge about 
the role of previous service use in the interplay of waiting time and outcomes, our results have 
to be interpreted as representative for a patient cohort with relatively high mental health service 
use in the past. If there were systematic differences in HoNOS coding quality between providers 
which in turn may be associated with the provider’s performance regarding patient waiting times 
and outcomes, we have controlled for these through the use of provider fixed effects.  
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Finally, the estimated effect is based on the assumption that the baseline health outcome 
conditional on other individual characteristics, including previous service use and treatment 
intensity, is sufficient to account for the individual’s unobserved pre-treatment severity. We find 
the baseline outcome to be a strong predictor for the follow-up outcome. Also, accounting for 
previous service use and treatment intensity may have captured some remaining severity not 
observed by the baseline HoNOS. However, there may still have remained unobserved severity 
that explains both longer waiting times and worse outcomes. Future research should aim to 
consider either a valid instrument or a suitable comparison group to deal with this challenge. 
Our results have direct implications for the recently introduced waiting time target policy for EIP 
services. As has been the case in many previous target policies in other health areas, the 14-day 
target appears to have been chosen arbitrarily rather than based on evidence. A comprehensive 
discussion on the optimal targeted waiting time needs to consider the effects on patient outcomes 
but also implications for the supply side. Our paper sheds some light on the demand dimension. 
According to our results, the target policy can only be effective in improving patient outcomes 
if it leads to a reduction in excessive waits longer than 3 months. 
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APPENDIX 
Appendix A Health of the Nation Outcome Scale (HoNOS) items, sub-domains and total score 
HoNOS item HoNOS sub score Total HoNOS score 
1.  Aggression A: Behaviour 
(max. score = 12) 
Total HoNOS score  
(max. score = 48) 2.  Self-harm 
3.  Drug & alcohol use 
4.  Cognitive problems B: Impairment 
(max. score = 8) 5.  Physical illness & disability 
6.  Hallucinations & delusions C: Symptoms 
(max. score = 12) 7.  Depression 
8.  Other symptoms 
9.  Relationships D: Social 
(max. score = 16) 10.  Activities in daily living 
11.  Residential environment 
12.  Day-time activities 
Note: Based on Wing et al. (1998); Wing et al. (1999). 
 
Appendix B Reliable and clinically significant change  
For more details, we refer the interested reader to Jacobson et al. (1991) and Parabiaghi et al. 
(2005). A reliable and clinically significant change satisfies two criteria: (1) a clinically 
significant change would move a person from a score typical of the “dysfunctional” population 
to a score typical of the “functional” population, and (2) a reliable change is beyond what could 
be attributed to measurement error or chance.  
(1) Clinically significant change: 
Patients were defined as dysfunctional if they had a score of ≥ 3 in at least two of the 12 items. 
All others made up the functional population. The cut-off point where the chance of belonging 
to either population (dysfunctional or functional) is equal is calculated as follows: 
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cut-off			
meandysfunc	×	SDfunc		meanfunc	×	SDdysfunc	
SD 	×	SD
= 	
(17.9×4.5)+(8.9×5.5)	
(4.5 + 5.5)
= 13.0 
A change of at least 13 score points in HoNOS was considered as clinically significant. 
(2) Reliable change 
We calculated a reliable change index (RCindex) based on the baseline HoNOS score: 
RCindex=	1.96×SEdiff = 1.96	×5.2	 	10.2	 
where SEdiff is the standard error of measurement of a difference:  
SEdiff = SD1×√2×√1-α = 6.8×√2×√1-0.71 = 5.2 
SD1 is the standard deviation of the baseline score and α is Cronbach’s coefficient. A change of 
at least 10 score points in HoNOS was considered as reliable.  
Based on this, we classified patients with a given HoNOS at baseline (score1) and follow-up 
(score2) as improved if score2		RCimprov	,	where	RCimprov=	score1	RCindex and deteriorated if 
score2	≤	RCdeter	,	where	RCdeter=	score1 − 	RCindex. In the study sample, 77.4% were classified as 
stable, 18.7% improved, and 3.9% deteriorated. 
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Appendix C Generalised Linear Model diagnostics - dependent variable: total HoNOS score at 
follow-up 
Test for normality of follow-up HoNOS 
      
  
  Obs W V z Prob>z 
Shapiro-Wilk test 8,949 0.98 103.33 12.38 0.000 
Shapiro-Francia test 8,949 0.98 109.33 12.32 0.000 
Within/between provider variance in follow-up HoNOS       
  Mean SD Min Max      Obs 
Overall variance 50.01 74.1 0 365      N = 8,949 
between provider variance   29.1 0 133.0      n = 48 
within provider variance   69.5 -82.9 380.7      T-bar = 186.44 
GLM model diagnostics based on model with independent variable: log waiting time 
Log pseudolikelihood -36006   
     
Squared correlation btw. y and yhat 0.183         
Linktest yhat P>|t| = 0.000       
Linktest yhat squared P>|t| = 0.051       
Hosmer-Lemeshow test F(10, 8939) = 0.42; Prob>F = 0.9385   
Ramsey RESET test chi2(1) = 5.78; Prob>chi2 = 0.0162   
Park test Gaussian chi2(1) = 26.12; Prob>chi2 = 0.0000 
  Poisson   chi2(1) = 2.20; Prob>chi2 = 0.1376 
  Gamma   chi2(1) = 4.59; Prob>chi2 = 0.0322 
  Inverse Gaussian chi2(1) = 33.26; Prob>chi2 = 0.0000 
 
Appendix D Seemingly Unrelated Regression results - dependent variable: HoNOS sub score at 
follow-up 
  (1) Behaviour (2) Impairment (3) Symptoms (4) Social 
  Coeff. SE Coeff. SE Coeff. SE Coeff. SE 
Log waiting time (continuous) 0.040** (0.014) 0.025** (0.009) 0.078*** (0.018) 0.061** (0.021) 
Waiting time quintiles (ref.cat.: shortest quintile)             
2nd shortest quintile -0.084 (0.076) -0.084 (0.049) -0.044 (0.100) -0.157 (0.117) 
3rd shortest quintile -0.111 (0.076) -0.009 (0.048) -0.060 (0.099) -0.218 (0.117) 
4th shortest quintile 0.055 (0.077) 0.076 (0.049) 0.068 (0.100) 0.004 (0.118) 
Longest quintile 0.145 (0.077) 0.053 (0.049) 0.341*** (0.101) 0.198 (0.118) 
Waiting time intervals (ref.cat.: less than 0.5 months)             
Waiting time 0.5 to 3 months 0.066 (0.048) 0.089** (0.031) 0.074 (0.063) 0.045 (0.074) 
Waiting time 3 to 6 months 0.146* (0.074) 0.078 (0.047) 0.295** (0.096) 0.259* (0.114) 
Waiting time 6 to 12 months 0.314*** (0.085) 0.154** (0.054) 0.516*** (0.111) 0.419** (0.130) 
Observations 8,949   8,949   8,949   8,949   
Provider and year fixed effects yes   yes   yes   yes   
Covariates yes   yes   yes   yes   
Note: * p<0.05, ** p<0.01, *** p<0.001. The dependent variable is in model (1) the HoNOS behaviour sub score (items 1-3), 
in model (2) the HoNOS impairment sub score (items 4-5), in model (3) the HoNOS symptoms sub score (items 6-8), in 
model (4) the HoNOS social sub score (items 9-12). 
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Appendix E Ordered probit estimation results - dependent variable: reliable and clinically 
significant change in total HoNOS score 
  
(1) Study sample (2) Long EIP (3) Short EIP 
Coeff. SE Coeff. SE Coeff. SE 
Log waiting time (continuous) 0.033** (0.012) 0.042** (0.014) 0.029 (0.020) 
Waiting time quintiles (ref.cat.: shortest quintile)    
2nd shortest quintile -0.066 (0.061) -0.052 (0.080) -0.083 (0.109) 
3rd shortest quintile -0.117* (0.058) -0.042 (0.075) -0.312** (0.108) 
4th shortest quintile -0.012 (0.054) -0.020 (0.063) 0.080 (0.127) 
Longest quintile 0.137* (0.064) 0.220** (0.083) 0.042 (0.101) 
Waiting time intervals (ref.cat.: less than 0.5 months) 
Waiting time 0.5 to 3 months -0.023 (0.040) -0.024 (0.046) 0.017 (0.069) 
Waiting time 3 to 6 months 0.122 (0.063) 0.216* (0.084) 0.048 (0.091) 
Waiting time 6 to 12 months 0.253*** (0.077) 0.290** (0.096) 0.239* (0.116) 
Observations 8,949   6,135   2,814   
Provider and year fixed effects yes   yes   yes   
Covariates yes   yes   yes   
Note: * p<0.05, ** p<0.01, *** p<0.001. Models (1) - (3) are ordered probit models with the dependent 
variable defined as:  1 = clinical improvement, 2 = clinical stability, 3 = clinical deterioration. Model (1) 
includes the complete study sample. Model (2) includes only patients that were in EIP care for the whole 
duration of follow-up. Model (3) includes only patients with an EIP episode shorter than the 12-months follow-
up.  All models use cluster robust standard errors for 48 provider clusters. 
 
